financetom
Business
financetom
/
Business
/
Japanese Auto Giants Nissan, Honda Eye Merger, Says Nikkei
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Japanese Auto Giants Nissan, Honda Eye Merger, Says Nikkei
Dec 17, 2024 2:20 PM

Japanese automakers Nissan Motor Co Ltd ( NSANF ) and Honda Motor Co Ltd ( HMC ) are reportedly negotiating a merger, first revealed by the Nikkei newspaper Tuesday, aiming to consolidate under a holding company and include Mitsubishi Motors.

What To Know: Per Nikkei, the combined Nissan-Honda-Mitsubishi group could account for over eight million annual vehicle sales, positioning it among the largest automakers but trailing Toyota Motor's 11.2 million and Volkswagen's 9.2 million.

Per a report by CNBC, Nissan and Honda ( HMC ) earlier declined to confirm the report, stating they are exploring collaborative opportunities without final decisions. Earlier this year, the firms partnered on shared components and software, potentially paving the way for integration.

The merger talks come as Nissan grapples with ongoing challenges, including weak profitability and recovering from a tumultuous period marked by the fallout from former Chairman Carlos Ghosn's ouster in 2018.

The company has also been under pressure to expand its electric vehicle offerings to compete with Tesla and Chinese rivals.

The response was positive, with Honda's ( HMC ) U.S.-traded shares rising 0.96% to $25.26 and Nissan's over-the-counter shares jumping 11.46% to $5.11 at market close on Tuesday.

Read Now:

Financial Stocks Near Record Year: Could Trump Deregulation Fuel Bigger Gains In 2025?

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2025 - www.financetom.com All Rights Reserved